• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pectoralis minor syndrome: diagnosis with Botulinum injection and treatment with tenotomy - a prospective case series.胸小肌综合征:肉毒杆菌注射诊断与腱切断术治疗——一项前瞻性病例系列研究
Shoulder Elbow. 2022 Apr;14(2):157-161. doi: 10.1177/1758573220968454. Epub 2020 Oct 25.
2
Recurrent neurogenic thoracic outlet syndrome stressing the importance of pectoralis minor syndrome.复发性神经源性胸廓出口综合征强调胸小肌综合征的重要性。
Vasc Endovascular Surg. 2011 Jan;45(1):33-8. doi: 10.1177/1538574410388311.
3
Arthroscopic release of the pectoralis minor tendon as an adjunct to acromioplasty in the treatment of subacromial syndrome associated with scapular dyskinesia.关节镜下胸小肌腱松解术联合肩峰成形术治疗伴有肩胛骨运动障碍的肩峰下综合征。
Orthop Traumatol Surg Res. 2022 Apr;108(2):103211. doi: 10.1016/j.otsr.2022.103211. Epub 2022 Jan 22.
4
Early effectiveness of isolated pectoralis minor tenotomy in selected patients with neurogenic thoracic outlet syndrome.选择性胸出口综合征神经源性患者中孤立性胸小肌肌腱切断术的早期疗效。
J Vasc Surg. 2013 May;57(5):1345-52. doi: 10.1016/j.jvs.2012.11.045. Epub 2013 Feb 1.
5
Role of Botulinum Toxin in Pectoralis Minor Syndrome.肉毒杆菌毒素在胸小肌综合征中的作用。
Ann Vasc Surg. 2022 Apr;81:225-231. doi: 10.1016/j.avsg.2021.09.032. Epub 2021 Nov 11.
6
Utilization and Effectiveness of Pectoralis Minor Tenotomy in the Surgical Management of Neurogenic Thoracic Outlet Syndrome.胸小肌切断术在神经源性胸廓出口综合征外科治疗中的应用及疗效
Hand (N Y). 2024 Oct 18:15589447241286240. doi: 10.1177/15589447241286240.
7
Arthroscopic release of the pectoralis minor tendon from the coracoid for pectoralis minor syndrome.关节镜下将胸小肌腱自喙突松解治疗胸小肌综合征。
J Exp Orthop. 2022 Jun 17;9(1):57. doi: 10.1186/s40634-022-00491-x.
8
The forgotten pectoralis minor syndrome: 100 operations for pectoralis minor syndrome alone or accompanied by neurogenic thoracic outlet syndrome.被遗忘的胸小肌综合征:100例单纯胸小肌综合征或合并神经源性胸廓出口综合征的手术治疗
Ann Vasc Surg. 2010 Aug;24(6):701-8. doi: 10.1016/j.avsg.2010.02.022. Epub 2010 May 14.
9
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.BoTULS 研究:一项多中心随机对照试验,旨在评估 A 型肉毒毒素治疗脑卒中后上肢痉挛的临床疗效和成本效益。
Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.
10
Outcome of arthroscopic pectoralis minor release and scapulopexy for the management of scapulothoracic abnormal motion.关节镜下胸小肌松解和肩胛固定术治疗肩胛胸壁异常运动。
J Shoulder Elbow Surg. 2022 Jun;31(6):1208-1214. doi: 10.1016/j.jse.2021.10.046. Epub 2021 Dec 7.

引用本文的文献

1
The Elias University Hospital Approach: A Visual Guide to Ultrasound-Guided Botulinum Toxin Injection in Spasticity: Part II-Proximal Upper Limb Muscles.伊莱亚斯大学医院方法:痉挛性疾病中超声引导下肉毒毒素注射视觉指南:第二部分——上肢近端肌肉。
Toxins (Basel). 2025 May 31;17(6):276. doi: 10.3390/toxins17060276.
2
An Uncommon Culprit: Trapezius Dystonia as a Cause of Thoracic Outlet Syndrome: A Case Report.一个不常见的病因:斜方肌肌张力障碍作为胸廓出口综合征的病因:一例报告
Cureus. 2024 Jul 4;16(7):e63825. doi: 10.7759/cureus.63825. eCollection 2024 Jul.
3
Ideal Injection Points for Botulinum Neurotoxin for Pectoralis Minor Syndrome: A Cadaveric Study.胸小肌综合征中肉毒杆菌神经毒素的理想注射点:尸体研究。
Toxins (Basel). 2023 Oct 7;15(10):603. doi: 10.3390/toxins15100603.

本文引用的文献

1
Exercise-Enhanced, Ultrasound-Guided Anterior Scalene Muscle/Pectoralis Minor Muscle Blocks Can Facilitate the Diagnosis of Neurogenic Thoracic Outlet Syndrome in the High-Performance Overhead Athlete.运动增强、超声引导下的前斜角肌/胸小肌阻滞有助于诊断高水平过头运动运动员的神经源性胸廓出口综合征。
Am J Sports Med. 2017 Jan;45(1):189-194. doi: 10.1177/0363546516665801. Epub 2016 Sep 30.
2
Thoracic outlet and pectoralis minor syndromes.胸廓出口综合征和胸小肌综合征
Semin Vasc Surg. 2014 Jun;27(2):86-117. doi: 10.1053/j.semvascsurg.2015.02.001. Epub 2015 Feb 18.
3
Determination and comparison of the smallest detectable change (SDC) and the minimal important change (MIC) of four-shoulder patient-reported outcome measures (PROMs).四种肩袖患者报告结局测量(PROMs)的最小可检测变化(SDC)和最小有意义变化(MIC)的测定和比较。
J Orthop Surg Res. 2013 Nov 14;8:40. doi: 10.1186/1749-799X-8-40.
4
Early effectiveness of isolated pectoralis minor tenotomy in selected patients with neurogenic thoracic outlet syndrome.选择性胸出口综合征神经源性患者中孤立性胸小肌肌腱切断术的早期疗效。
J Vasc Surg. 2013 May;57(5):1345-52. doi: 10.1016/j.jvs.2012.11.045. Epub 2013 Feb 1.
5
A review of thoracic outlet syndrome and the possible role of botulinum toxin in the treatment of this syndrome.综述胸廓出口综合征及肉毒毒素在该综合征治疗中的可能作用。
Toxins (Basel). 2012 Nov 7;4(11):1223-35. doi: 10.3390/toxins4111223.
6
Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial.肉毒杆菌毒素注射治疗胸廓出口综合征:一项双盲、随机、对照试验。
Pain. 2011 Sep;152(9):2023-2028. doi: 10.1016/j.pain.2011.04.027. Epub 2011 May 31.
7
Recurrent neurogenic thoracic outlet syndrome stressing the importance of pectoralis minor syndrome.复发性神经源性胸廓出口综合征强调胸小肌综合征的重要性。
Vasc Endovascular Surg. 2011 Jan;45(1):33-8. doi: 10.1177/1538574410388311.
8
Neurogenic thoracic outlet syndrome: A case report and review of the literature.神经源性胸廓出口综合征:一例病例报告及文献综述
Int J Shoulder Surg. 2010 Apr;4(2):27-35. doi: 10.4103/0973-6042.70817.
9
Diagnosis and assessment of neuropathic pain.神经性疼痛的诊断与评估
F1000 Med Rep. 2009 Oct 14;1:76. doi: 10.3410/M1-76.
10
The forgotten pectoralis minor syndrome: 100 operations for pectoralis minor syndrome alone or accompanied by neurogenic thoracic outlet syndrome.被遗忘的胸小肌综合征:100例单纯胸小肌综合征或合并神经源性胸廓出口综合征的手术治疗
Ann Vasc Surg. 2010 Aug;24(6):701-8. doi: 10.1016/j.avsg.2010.02.022. Epub 2010 May 14.

胸小肌综合征:肉毒杆菌注射诊断与腱切断术治疗——一项前瞻性病例系列研究

Pectoralis minor syndrome: diagnosis with Botulinum injection and treatment with tenotomy - a prospective case series.

作者信息

Howard Matthew, Jones Michael, Clarkson Richard, Donaldson Oliver

机构信息

Department of Trauma and Orthopaedics, Yeovil District Hospital, Yeovil, UK.

出版信息

Shoulder Elbow. 2022 Apr;14(2):157-161. doi: 10.1177/1758573220968454. Epub 2020 Oct 25.

DOI:10.1177/1758573220968454
PMID:35265181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8899325/
Abstract

BACKGROUND

Pectoralis minor syndrome involves pain, paraesthesia and weakness in the arm due to compression of the brachial plexus passing beneath pectoralis minor; this paper reports the results of a single centre's treatment pathway in affected patients.

METHODS

During a four-year period, patients exhibiting symptoms of pectoralis minor syndrome without significant improvement following physiotherapy proceeded to Botulinum injection. Those with good response to injection but subsequent recurrence of symptoms were offered pectoralis minor tenotomy. Oxford shoulder Scores were collected at baseline and after interventions.

RESULTS

Twenty-one patients received Botulinum injection; at six weeks following injection, mean change in Oxford Shoulder Score was +12.4, with only one patient reporting a worsening of symptoms. Of the 17 patients with clinically significant response to injection, 12 have subsequently undergone tenotomy; three months following tenotomy, mean change in Oxford Shoulder Score from baseline was +22.3. Improvement was maintained in all patients at prolonged follow-up (average 20 months post-tenotomy).

DISCUSSION

This pathway has shown to be extremely effective in patients not responding to first-line treatment for pectoralis minor syndrome, with 85% of patients post-injection and 100% of patients post-tenotomy showing significant (greater than published minimal clinically important difference value of six points) improvements in Oxford Shoulder Score, maintained at follow-up.

摘要

背景

胸小肌综合征是由于臂丛神经在胸小肌下方受到压迫,导致手臂出现疼痛、感觉异常和无力;本文报告了一个单一中心对受影响患者的治疗方案结果。

方法

在四年期间,表现出胸小肌综合征症状且物理治疗后无明显改善的患者接受肉毒杆菌注射。对注射有良好反应但随后症状复发的患者接受胸小肌切断术。在基线和干预后收集牛津肩部评分。

结果

21例患者接受了肉毒杆菌注射;注射后六周,牛津肩部评分的平均变化为+12.4,只有1例患者报告症状恶化。在对注射有临床显著反应的17例患者中,12例随后接受了切断术;切断术后三个月,牛津肩部评分相对于基线的平均变化为+22.3。在长期随访(切断术后平均20个月)中,所有患者的改善情况均得以维持。

讨论

该治疗方案已证明对胸小肌综合征一线治疗无反应的患者极为有效,注射后85%的患者以及切断术后1​​00%的患者在牛津肩部评分上有显著改善(大于已发表的最小临床重要差异值6分),且在随访中得以维持。